Gary W. Boyd
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
-
- Carcinogens and Genotoxicity Assessment 4
- Co-authors
- Duncan Ian Jodrell (7 shared papers)MOIRA S. LEWITT (3 shared papers)Rhona E. Aird (1 shared paper)Simon Parsons (1 shared paper)Andrew Parkin (1 shared paper)Haimei Chen (1 shared paper)Jeff Cummings (2 shared papers)Piedad del Socorro Murdoch (1 shared paper)
- Journals
- Carcinogenesis (4 papers)Biochemical Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Chromatographia (1 paper)Toxicology (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Gary W. Boyd
24 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 64
- Oncology 608
- Pharmacology 63
- Organic Chemistry 66
- Developmental Neuroscience 5
- Analytical Chemistry 18
Countries citing papers authored by Gary W. Boyd
This map shows the geographic impact of Gary W. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Boyd more than expected).
Fields of papers citing papers by Gary W. Boyd
This network shows the impact of papers produced by Gary W. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Boyd. The network helps show where Gary W. Boyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary W. Boyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 736 | |
| 2 | 2019 | 126 | |
| 3 | Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives. | 2003 | 74 |
| 4 | 2002 | 73 | |
| 5 | 2003 | 59 | |
| 6 | 2002 | 48 | |
| 7 | 2003 | 46 | |
| 8 | 2001 | 32 | |
| 9 | 1999 | 30 | |
| 10 | 2002 | 16 | |
| 11 | 1995 | 10 | |
| 12 | 2024 | 9 | |
| 13 | 2009 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 1995 | 6 | |
| 16 | 1995 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 1993 | 5 | |
| 19 | 1993 | 4 | |
| 20 | 1993 | 4 |
About Gary W. Boyd
Gary W. Boyd is a scholar working on Pharmacology, Cancer Research, Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer therapeutics and mechanisms (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Drug Transport and Resistance Mechanisms (1 paper), Blood Coagulation and Thrombosis Mechanisms (1 paper) and Metal complexes synthesis and properties (1 paper). The work is most often cited by research in Oncology (608 citations), Pharmacology (63 citations), Organic Chemistry (66 citations), Developmental Neuroscience (5 citations) and Analytical Chemistry (18 citations). Gary W. Boyd has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Duncan Ian Jodrell, MOIRA S. LEWITT, Rhona E. Aird, Simon Parsons, Andrew Parkin, Haimei Chen, Jeff Cummings, Piedad del Socorro Murdoch, Peter John Sadler and Robert A. Morris. Their work appears in journals such as Carcinogenesis, Biochemical Pharmacology, Cancer Chemotherapy and Pharmacology, Chromatographia and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.